Xencor, Inc. (XNCR)
14.43
+0.49
(+3.52%)
USD |
NASDAQ |
Jan 14, 16:00
14.43
0.00 (0.00%)
After-Hours: 20:00
Xencor EPS Diluted (Quarterly): -0.081 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Glaukos Corp. | -0.2828 |
| Boston Scientific Corp. | 0.5048 |
| Ironwood Pharmaceuticals, Inc. | 0.2294 |
| GT Biopharma, Inc. | -0.8268 |
| Nuvalent, Inc. | -1.697 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.027M |
| Revenue (Quarterly) | 21.00M |
| Total Expenses (Quarterly) | 27.03M |
| Enterprise Value | 726.82M |
| Gross Profit Margin (Quarterly) | 87.62% |
| Profit Margin (Quarterly) | -28.70% |
| Earnings Yield | -12.31% |
| Normalized Earnings Yield | -15.23 |